Cargando…
SAT220 Rare Case Of Pembrolizumab Induced Primary Hypoparathyroidism
Disclosure: S.G. Goud: None. A. Siddiqui: None. M. Alkhathlan: None. C.Y. Fan: None. Introduction: Immune checkpoint inhibitors such as pembrolizumab (Keytruda) used in the treatment of various cancers are associated with immune mediated endocrinopathies, among which thyroid dysfunction and pituitar...
Autores principales: | Goud, Sarita G, Siddiqui, Ayesha, Alkhathlan, Mujahed, Ying Fan, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553992/ http://dx.doi.org/10.1210/jendso/bvad114.517 |
Ejemplares similares
-
SAT244 Hypercalcemia Induced By Inconspicuous Histoplasmosis Infection
por: Alkhathlan, Mujahed, et al.
Publicado: (2023) -
SAT-354 Isolated Hypoparathyroidism: A Rare Initial Manifestation of Hereditary Hemochromatosis (HH)
por: Shaheen, Zainab, et al.
Publicado: (2020) -
SAT234 Variations In Clinical Practice Patterns For Hypoparathyroidism
por: Deering, Kathleen L, et al.
Publicado: (2023) -
SAT224 Nonsurgical Hypoparathyroidism: 40 Years After Diagnosis
por: Ilyse Kaplan, Leah, et al.
Publicado: (2023) -
SAT-335 New Onset Adult Idiopathic Primary Hypoparathyroidism Concomitant with Severe Aplastic Anemia
por: Galustian, Sophia, et al.
Publicado: (2020)